NHS Greater Glasgow & Clyde Area Drug and Therapeutics Committee
Greater Glasgow and Clyde Prescribing
Greater Glasgow and Clyde Prescribing
Where combination preparations include several medicines from the same class, they are included in that particular sub-section (e.g. protease inhibitors). Cross-class combinations can be found in sub-section 5.3.1.5.
Restrictions: Restricted to use by HIV specialists.
BNF Link: http://www.medicinescomplete.com/mc/bnf/current/81977.htm
Restrictions: Restricted to use by HIV specialists.
BNF Link: http://www.medicinescomplete.com/mc/bnf/current/81977.htm
Restrictions: Restricted to use by HIV specialists.
BNF Link: http://www.medicinescomplete.com/mc/bnf/current/129292.htm#_129292
Restrictions: Restricted to use by HIV specialists.
BNF Link: http://www.medicinescomplete.com/mc/bnf/current/21584.htm
Restrictions: Restricted to use by HIV specialists.
BNF Link: http://www.medicinescomplete.com/mc/bnf/current/128251.htm
Restrictions: Restricted to use by HIV specialists.
BNF Link: http://www.medicinescomplete.com/mc/bnf/current/57101.htm
Restrictions: Restricted to use by HIV specialists.
BNF Link: http://www.medicinescomplete.com/mc/bnf/current/57102.htm
Restrictions: Restricted to use by HIV specialists.
Prescribing Notes:
For treatment of hepatitis B see section 5.3.3.
BNF Link: http://www.medicinescomplete.com/mc/bnf/current/106524.htm
Restrictions: Restricted to use by HIV specialists.
BNF Link: http://www.medicinescomplete.com/mc/bnf/current/129299.htm#_129299
Restrictions: Restricted to use by HIV specialists.
BNF Link: http://www.medicinescomplete.com/mc/bnf/current/4002.htm
Restrictions: Restricted to use by HIV specialists.
BNF Link: http://www.medicinescomplete.com/mc/bnf/current/69459.htm#_69459
Restrictions: Restricted to use by HIV specialists. Use in naïve HIV-1 infected adults in combination with other antiretrovirals is further restricted to when other treatments are not tolerated or inappropriate.
BNF Link: http://www.medicinescomplete.com/mc/bnf/current/128409.htm
Restrictions: Restricted to use by HIV specialists.
BNF Link: http://www.medicinescomplete.com/mc/bnf/current/130109.htm
Restrictions: Restricted to use by HIV specialists.
BNF Link: http://www.medicinescomplete.com/mc/bnf/current/128976.htm
Restrictions: Restricted to use by HIV specialists.
BNF Link: http://www.medicinescomplete.com/mc/bnf/current/57103.htm
Restrictions: Restricted to use by HIV specialists.
BNF Link: http://www.medicinescomplete.com/mc/bnf/current/69466.htm
Restrictions: Restricted to use by HIV specialists.
BNF Link: http://www.medicinescomplete.com/mc/bnf/current/57104.htm
Restrictions: Restricted to use by HIV specialists.
BNF Link: http://www.medicinescomplete.com/mc/bnf/current/106116.htm
Restrictions: Restricted to use by HIV specialists.
BNF Link: http://www.medicinescomplete.com/mc/bnf/current/57106.htm
Restrictions: Restricted to use by HIV specialists.
BNF Link: http://www.medicinescomplete.com/mc/bnf/current/129518.htm
Restrictions: Restricted to use by HIV specialists.
BNF Link: http://www.medicinescomplete.com/mc/bnf/current/78513.htm
Restrictions: Restricted to use by HIV specialists.
BNF Link: http://www.medicinescomplete.com/mc/bnf/current/201547.htm
Restrictions: Restricted to use by HIV specialists.
Prescribing Notes:
Potentially fatal liver toxicity and skin reactions have been reported.
BNF Link: http://www.medicinescomplete.com/mc/bnf/current/69473.htm
Restrictions: The combination treatment of HIV-1 infection in treatment naive adults is restricted to HIV specialists.
Restrictions: Restricted to use by HIV specialists.
BNF Link: http://www.medicinescomplete.com/mc/bnf/current/128190.htm
Restrictions: Restricted to use by HIV specialists in patients with triple-class resistant HIV-1 infection or in combination with other treatments in adult patients who are intolerant or resistant to non-nucleoside reverse transcriptase inhibitors (NNRTIs) or protease inhibitors (PIs) or when these options are compromised due to drug-drug interactions.
BNF Link: http://www.medicinescomplete.com/mc/bnf/current/200998.htm
Combination preparations that consist of drugs from the different classes of HIV medicines are included in this sub-section.
Restrictions: Restricted to use by HIV specialists.
BNF Link: http://www.medicinescomplete.com/mc/bnf/current/200890.htm#_200890
Restrictions: The use for the treatment of HIV-1 infection in treatment naive adults is restricted to HIV specialists only
Prescribing Notes:
Aciclovir and other antiviral agents are only useful in varicella and herpes zoster if started within 48 hours of the appearance of rash, with the exception of ophthalmic shingles where the use may be justified up to 7 days after the development of rash.
BNF Link: http://www.medicinescomplete.com/mc/bnf/current/3994.htm
Prescribing Notes:
Not approved for genital herpes.
BNF Link: http://www.medicinescomplete.com/mc/bnf/current/14826.htm
Restrictions: Not approved for prevention of recurrent herpes.
BNF Link: http://www.medicinescomplete.com/mc/bnf/current/33566.htm
Restrictions: Restricted to use by HIV specialists.
BNF Link: http://www.medicinescomplete.com/mc/bnf/current/64326.htm
Restrictions: Restricted to use by HIV specialists.
BNF Link: http://www.medicinescomplete.com/mc/bnf/current/4007.htm
Restrictions: Restricted to use by HIV specialists.
BNF Link: http://www.medicinescomplete.com/mc/bnf/current/4005.htm
Restrictions: Use in HIV and Ophthalmology is restricted to specialist use by HIV specialists and ophthalmologists specialising in ocular issues associated with HIV infection respectively. The use of valganciclovir for the prevention of cytomegalovirus (CMV) disease for patients who have received a solid organ transplantation from a CMV postive donor is restricted to initiation by physicians experienced in the care of post-transplant patients. However, GPs are able to prescribe on the advice of a specialist for this indication in order to complete the course duration (which may vary between 100-200 days dependent on type of organ transplanted).
BNF Link: http://www.medicinescomplete.com/mc/bnf/current/106526.htm
Restrictions: Restricted to initiation by, or on the advice of, a specialist treating hepatitis B in accordance with local protocol.
BNF Link: http://www.medicinescomplete.com/mc/bnf/current/127968.htm
Restrictions: Restricted to initiation by, or on the advice of, a specialist treating hepatitis B in accordance with local protocol. Use for the treatment of chronic hepatitis B infection in adults with decompensated liver disease is not recommended by SMC and is non-Formulary.
BNF Link: http://www.medicinescomplete.com/mc/bnf/current/129890.htm
Restrictions: Restricted to initiation by, or on the advice of, a specialist treating hepatitis B in accordance with local protocol.
BNF Link: http://www.medicinescomplete.com/mc/bnf/current/57101.htm
Restrictions: Restricted to specialist use only. Use subject to Hepatitis MCN protocol with pegylated interferon alfa in hepatitis C.
BNF Link: http://www.medicinescomplete.com/mc/bnf/current/4010.htm
Restrictions: Restricted to initiation by, or on the advice of, a specialist treating hepatitis B in accordance with local protocol.
BNF Link: http://www.medicinescomplete.com/mc/bnf/current/106524.htm
Restrictions: Restricted to use by consultants for the treatment of chronic hepatitis C (HCV) genotype 1 infection in combination with peginterferon alfa and ribavirin in adult patients (both treatment naive and treatment experienced) in accordance with local protocol
BNF Link: http://www.medicinescomplete.com/mc/bnf/current/217023.htm
Restrictions: The treatment of genotype 1 chronic hepatitis C in combination with peginterferon alfa and ribavirin in adult patients (both treatment naive and treatment experienced) is restricted to consultant use only in accordance with local protocol.
BNF Link: http://www.medicinescomplete.com/mc/bnf/current/217728.htm
Restrictions: Oseltamivir use in the prophylaxis of influenza is subject to NICE TA158 and the treatment of influenza is subject to NICE TA168.
BNF Link: http://www.medicinescomplete.com/mc/bnf/current/119743.htm
Restrictions: Zanamivir use in the prophylaxis of influenza is subject to NICE TA158 and the treatment of influenza is subject to NICE TA168.
BNF Link: http://www.medicinescomplete.com/mc/bnf/current/82108.htm
Restrictions: Restricted to specialist initiation. Restricted to use as indicated in West of Scotland protocol.
BNF Link: http://www.medicinescomplete.com/mc/bnf/current/82140.htm
Restrictions: Restricted to specialist initiation.
BNF Link: http://www.medicinescomplete.com/mc/bnf/current/4010.htm